LifeStance Health Group (NASDAQ:LFST) Hits New 12-Month High – What’s Next?

LifeStance Health Group, Inc. (NASDAQ:LFST) reached a new 52-week high on Wednesday. The stock traded as high as $13.77 and last traded at $13.6480, with a volume of 109,401 shares trading hands. The stock had previously closed at $13.37.

Analyst Ratings Changes

A number of analysts recently commented on LFST shares. Wall Street Zen cut LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, September 5th. Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 13th. KeyCorp lifted their target price on LifeStance Health Group from $13.00 to $15.00 and gave the company an “overweight” rating in a research report on Monday, October 5th. Barclays boosted their price target on LifeStance Health Group from $13.00 to $15.00 and gave the company an “overweight” rating in a report on Thursday, September 10th. Finally, Weiss Ratings upgraded LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $13.12.

LifeStance Health Group Stock Performance

The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. The business’s 50 day moving average is $12.52 and its two-hundred day moving average is $9.40. The company has a market cap of $5.36 billion, a PE ratio of 107.89 and a beta of 1.35.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%. The business had revenue of $435.35 million during the quarter, compared to analyst estimates of $414.58 million. During the same quarter in the prior year, the business posted ($0.01) EPS. LifeStance Health Group’s revenue for the quarter was up 26.1% compared to the same quarter last year. On average, equities research analysts anticipate that LifeStance Health Group, Inc. will post 0.16 EPS for the current year.

Insider Transactions at LifeStance Health Group

In related news, CTO Vukasin Paunovich sold 44,394 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $10.85, for a total value of $481,674.90. Following the transaction, the chief technology officer directly owned 247,446 shares of the company’s stock, valued at approximately $2,684,789.10. The trade was a 15.21% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Lisa K. Miller sold 47,912 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $10.85, for a total value of $519,845.20. Following the completion of the transaction, the chief operating officer owned 281,289 shares of the company’s stock, valued at $3,051,985.65. The trade was a 14.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 13,777,580 shares of company stock valued at $146,433,781 over the last 90 days. Company insiders own 3.50% of the company’s stock.

Institutional Trading of LifeStance Health Group

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Summit Creek Advisors LLC purchased a new stake in LifeStance Health Group in the 3rd quarter worth $2,408,000. StoneX Group Inc. purchased a new position in shares of LifeStance Health Group during the third quarter valued at about $132,000. Pictet Asset Management Holding SA grew its position in shares of LifeStance Health Group by 56.6% during the third quarter. Pictet Asset Management Holding SA now owns 41,302 shares of the company’s stock valued at $497,000 after purchasing an additional 14,936 shares in the last quarter. Commonwealth Equity Services LLC bought a new stake in shares of LifeStance Health Group in the third quarter worth about $144,000. Finally, Oregon Public Employees Retirement Fund increased its holdings in shares of LifeStance Health Group by 16.6% in the third quarter. Oregon Public Employees Retirement Fund now owns 60,500 shares of the company’s stock worth $728,000 after purchasing an additional 8,600 shares during the last quarter. 85.50% of the stock is currently owned by institutional investors.

About LifeStance Health Group

LifeStance Health Group, Inc is a provider of outpatient behavioral health services in the United States. Through a network of clinicians and care centers, the company offers mental health care through in-person appointments and telehealth visits.

LifeStance’s services include individual, couples and family therapy; psychiatric evaluation and medication management; psychological and neuropsychological testing; and treatment for conditions such as depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, post-traumatic stress disorder and other behavioral health concerns.